发明名称 Vector for tissue-specific replication and gene expression
摘要 The invention generally relates to cell-specific expression vectors. It particularly relates to targeted gene therapy using recombinant expression vectors and particularly adenovirus vectors. The invention specifically relates to replication-conditional expression vectors and methods for using them. Such vectors are able to selectively replicate in a target cell or tissue to provide a therapeutic benefit in a tissue from the presence of the vector per se or from one or more heterologous gene products expressed from the vector and distributed throughout the tissue. In such vectors, a gene essential for replication is placed under the control of a heterologous tissue-specific transcriptional regulatory sequence. Thus, replication is conditioned on the presence of a factor(s) that induces transcription or the absence of a factor(s) that inhibits transcription of the gene by means of the transcriptional regulatory sequence with this vector; therefore, a target tissue can be selectively treated.
申请公布号 AU1755299(A) 申请公布日期 1999.06.07
申请号 AU19990017552 申请日期 1998.11.17
申请人 NOVARTIS AG 发明人 PAUL L HALLENBECK;CARL M. HAY;DAVID A. STEWART
分类号 C12N15/09;A61K31/711;A61K35/76;A61K38/00;A61K38/44;A61K39/23;A61K39/235;A61K39/245;A61K39/29;A61K48/00;A61P35/00;C12N5/10;C12N7/00;C12N7/01;C12N15/861 主分类号 C12N15/09
代理机构 代理人
主权项
地址